CompletedNCT01808729
CAUSE Trial: Patient Specific-Cellular Characterization of Fibromuscular Dysplasia and High-Risk Atherosclerotic Endothelium
Studying Fibromuscular dysplasia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Principal Investigator
- Jason Kovacic, MDIcahn School of Medicine at Mount Sinai
- Enrollment
- 34 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2013 – 2013
Study locations (1)
- Icahn School of Medicine at Mount Sinai, New York, New York, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01808729 on ClinicalTrials.govOther trials for Fibromuscular dysplasia
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT04804683European/International FMD Registry and InitiativeCliniques universitaires Saint-Luc- Université Catholique de Louvain
- RECRUITINGNCT04906356Canadian SCAD StudyCardiology Research UBC
- RECRUITINGNCT01967511Defining the Basis of Fibromuscular Dysplasia (FMD)Icahn School of Medicine at Mount Sinai